Boston Scientific Corporation
Market Cap
$85.62B
P/E Ratio
24.10
EPS
$2.39
Dividend Yield
0.00%
52-Week Range
$56.05 — $109.50
Volume
17.95M
Avg Volume
17.72M
Beta
0.78
Get alerted when BSX hits your target price.
Free — enter your email to get started
P/E (TTM)
24.10
Forward P/E
16.64
PEG Ratio
0.35
P/S (TTM)
4.47
P/B (TTM)
3.80
P/FCF
124.49
EV/EBITDA
113.62x
EV/Sales
—
ROE (TTM)
0.15%
ROA (TTM)
0.08%
ROIC
0.03%
Gross Margin
0.70%
Operating Margin
0.20%
Net Margin
0.15%
Debt/Equity
0.51
Current Ratio
1.62
EPS Growth (YoY)
+0.60%
Revenue Growth (YoY)
+0.20%
EPS Growth (3Y)
+0.71%
EPS Growth (5Y)
+2.26%
Sales Growth (3Y)
+0.17%
Sales Growth (5Y)
+0.15%
EPS Est (This Year)
$3.46
EPS Est (Next Year)
$3.92
Dividend Yield
—
Annual Dividend
—
Payout Ratio
0.00%
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.38
Buy
1 = Strong Buy, 5 = Strong Sell
Price Target Range
Consensus Target: $108.35(88.1% upside)
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
1.48B
Float
1.48B
Free Float %
99.70%
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
NYSE
IPO Date
1992-05-19
Employees
53000
CEO
Michael F. Mahoney
Index Membership
S&P 500
Website
https://www.bostonscientific.com
Boston Scientific Corporation (BSX) is a healthcare company in the medical - devices industry listed on the NYSE. With a market capitalization of $85.62B, a P/E ratio of 24.10, BSX is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare BSX against other stocks using dozens of fundamental and technical filters.
Boston Scientific Corporation (BSX) has a trailing twelve-month (TTM) P/E ratio of 24.10. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, Boston Scientific Corporation (BSX) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
Boston Scientific Corporation (BSX) has a market capitalization of $85.62 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.
Wall Street analysts have a consensus "Buy" rating on Boston Scientific Corporation (BSX) with an average score of 2.00 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $108.35 implies 88.1% upside from the current price.